News Tagged ‘cardiovascular disease’

Prempro increases risk of dying from small cell lung cancer

Women who took Wyeth’s hormone replacement therapy () Prempro at least five years are at greater risk of dying from non-small cell lung cancer, according to a recent study presented at an American Society of Clinical Oncology meeting.

Read the rest of this entry »

Cancer risk still elevated even years after stopping HRT

A study in the Journal of the American Medical Association (JAMA) reveals that women who took hormone replacement therapy (HRT) face an increased risk of cancer several years after stopping the treatment, according to an NPR report.

Read the rest of this entry »

Wyeth faces more lawsuits for promoting sales despite concerns

In the 1960s, a New York gynecologist wrote a book called “Feminine Forever,” in which he recommended estrogen for menopause, stating that women on the replacement drug “will be much more pleasant to live with and will not become dull and unattractive.”

Wyeth Pharmaceuticals caught wind of the book and its author’s claims that estrogen reduced a woman’s risk for both breast and genital cancers, and began distributing the book to physicians across the country. Soon after, sales of Wyeth’s drug Premarin took off, growing to more than 30 million prescriptions each year.

Read the rest of this entry »

Report cites drop in cancer rates among men and women

Two years ago, M.D. Anderson researchers announced a 7 percent drop in rates which coincidentally occurred around the same time that women were being told by the media and their doctors of the possible link between hormone replacement therapy (HRT) and serious diseases and conditions such as and heart disease.

Read the rest of this entry »